Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 603

1.

A CuAAC Click Approach for the Introduction of Bidentate Metal Complexes to a Sulfanilamide-Derived Antibiotic Fragment.

Miller RG, Vázquez-Hernández M, Prochnow P, Bandow JE, Metzler-Nolte N.

Inorg Chem. 2019 Jul 15;58(14):9404-9413. doi: 10.1021/acs.inorgchem.9b01186. Epub 2019 Jun 27.

PMID:
31246015
2.

Periodontal disease, smoking, cardiovascular complications and mortality in type 1 diabetes.

Khouja T, Miller RG, Moore PA, Orchard TJ, Costacou T.

J Diabetes Complications. 2019 Jun 3. pii: S1056-8727(19)30165-5. doi: 10.1016/j.jdiacomp.2019.05.025. [Epub ahead of print]

PMID:
31235433
3.

Excess mortality and cardiovascular disease risk in type 1 diabetes.

Costacou T, Guo J, Miller RG, Orchard TJ.

Lancet. 2019 Mar 9;393(10175):985. doi: 10.1016/S0140-6736(18)33047-2. No abstract available.

PMID:
30860050
4.

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.

van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Benatar M, Berry JD, Chio A, Corcia P, Genge A, Gubitz AK, Lomen-Hoerth C, McDermott CJ, Pioro EP, Rosenfeld J, Silani V, Turner MR, Weber M, Brooks BR, Miller RG, Mitsumoto H; Airlie House ALS Clinical Trials Guidelines Group.

Neurology. 2019 Apr 2;92(14):e1610-e1623. doi: 10.1212/WNL.0000000000007242. Epub 2019 Mar 8.

5.

Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.

Guo J, Nunley KA, Costacou T, Miller RG, Rosano C, Edmundowicz D, Orchard TJ.

Atherosclerosis. 2019 Jan;280:58-65. doi: 10.1016/j.atherosclerosis.2018.11.003. Epub 2018 Nov 8.

PMID:
30471556
6.

Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension.

Ray EC, Miller RG, Demko JE, Costacou T, Kinlough CL, Demko CL, Unruh ML, Orchard TJ, Kleyman TR.

Kidney Int Rep. 2018 Jun 30;3(6):1434-1442. doi: 10.1016/j.ekir.2018.06.007. eCollection 2018 Nov.

7.

The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes.

Guo J, Erqou SA, Miller RG, Edmundowicz D, Orchard TJ, Costacou T.

Diabetologia. 2019 Feb;62(2):259-268. doi: 10.1007/s00125-018-4764-2. Epub 2018 Nov 14.

PMID:
30426170
9.

A research agenda for seed-trait functional ecology.

Saatkamp A, Cochrane A, Commander L, Guja LK, Jimenez-Alfaro B, Larson J, Nicotra A, Poschlod P, Silveira FAO, Cross AT, Dalziell EL, Dickie J, Erickson TE, Fidelis A, Fuchs A, Golos PJ, Hope M, Lewandrowski W, Merritt DJ, Miller BP, Miller RG, Offord CA, Ooi MKJ, Satyanti A, Sommerville KD, Tangney R, Tomlinson S, Turner S, Walck JL.

New Phytol. 2019 Mar;221(4):1764-1775. doi: 10.1111/nph.15502. Epub 2018 Oct 25.

PMID:
30269352
10.

Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes.

Williams KV, Cristaldi CL, Miller RG, Arena VC, Libman I, Huang Y, Becker DJ, Orchard TJ.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3828-3836. doi: 10.1210/jc.2018-00908.

PMID:
30099548
11.

Evaluation of a Diabetes Prevention Program Lifestyle Intervention in Older Adults: A Randomized Controlled Study in Three Senior/Community Centers of Varying Socioeconomic Status.

Kramer MK, Vanderwood KK, Arena VC, Miller RG, Meehan R, Eaglehouse YL, Schafer G, Venditti EM, Kriska AM.

Diabetes Educ. 2018 Apr;44(2):118-129. doi: 10.1177/0145721718759982. Epub 2018 Mar 7.

PMID:
29514568
12.

Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial.

Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, Joyce NC, Mandeville R, Goyal N, Cudkowicz ME, Weiss M, Miller RG, McDonald CM.

Muscle Nerve. 2018 Mar 6. doi: 10.1002/mus.26117. [Epub ahead of print]

PMID:
29510461
14.

Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.

Guo J, Miller RG, Costacou T, Follansbee WP, Orchard TJ.

J Diabetes Complications. 2018 Mar;32(3):298-304. doi: 10.1016/j.jdiacomp.2017.12.004. Epub 2017 Dec 28.

15.

Introduction to supplement: the current status of treatment for ALS.

Miller RG, Appel SH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):1-4. doi: 10.1080/21678421.2017.1361447.

PMID:
28872909
16.

From Enzymes to Functional Materials-Towards Activation of Small Molecules.

Möller F, Piontek S, Miller RG, Apfel UP.

Chemistry. 2018 Feb 1;24(7):1471-1493. doi: 10.1002/chem.201703451. Epub 2017 Nov 8. Review.

PMID:
28816379
17.

Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.

Bjornstad P, Costacou T, Miller RG, Maahs DM, Rewers MJ, Orchard TJ, Snell-Bergeon JK.

Diabet Med. 2017 Nov;34(11):1532-1540. doi: 10.1111/dme.13430. Epub 2017 Aug 14.

18.

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.

Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chiò A.

JAMA Neurol. 2017 Jun 1;74(6):660-667. doi: 10.1001/jamaneurol.2016.6179.

19.

Modulation of the CO2 fixation in dinickel azacryptands.

Möller F, Castañeda-Losada L, Junqueira JRC, Miller RG, Reback ML, Mallick B, van Gastel M, Apfel UP.

Dalton Trans. 2017 May 2;46(17):5680-5688. doi: 10.1039/c6dt04527h.

PMID:
28220915
20.

Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.

Diana A, Pillai R, Bongioanni P, O'Keeffe AG, Miller RG, Moore DH.

Cochrane Database Syst Rev. 2017 Jan 9;1:CD006049. doi: 10.1002/14651858.CD006049.pub2. Review.

21.

A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study.

Miller RG, Mahajan HD, Costacou T, Sekikawa A, Anderson SJ, Orchard TJ.

Diabetes Care. 2016 Dec;39(12):2296-2303. Epub 2016 Sep 21.

22.

Phase I clinical trial of safety of L-serine for ALS patients.

Levine TD, Miller RG, Bradley WG, Moore DH, Saperstein DS, Flynn LE, Katz JS, Forshew DA, Metcalf JS, Banack SA, Cox PA.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):107-111. doi: 10.1080/21678421.2016.1221971. Epub 2016 Sep 2.

PMID:
27589995
23.

Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial.

Eaglehouse YL, Rockette-Wagner B, Kramer MK, Arena VC, Miller RG, Vanderwood KK, Kriska AM.

Transl J Am Coll Sports Med. 2016 Jun 1;1(5):45-51.

24.

Diaphragm pacing in patients with amyotrophic lateral sclerosis.

Miller RG, Lewis RA.

Lancet Neurol. 2016 May;15(6):542. doi: 10.1016/S1474-4422(16)30012-6. Epub 2016 Apr 11. No abstract available.

PMID:
27302114
25.

Commensurate CO2 Capture, and Shape Selectivity for HCCH over H2CCH2, in Zigzag Channels of a Robust Cu(I)(CN)(L) Metal-Organic Framework.

Miller RG, Southon PD, Kepert CJ, Brooker S.

Inorg Chem. 2016 Jun 20;55(12):6195-200. doi: 10.1021/acs.inorgchem.6b00813. Epub 2016 Jun 3.

PMID:
27258550
26.

Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study.

Miller RG, Anderson SJ, Costacou T, Sekikawa A, Orchard TJ.

Diab Vasc Dis Res. 2016 Jul;13(4):250-9. doi: 10.1177/1479164116629353. Epub 2016 Apr 21.

27.

Reversible quantitative guest sensing via spin crossover of an iron(ii) triazole.

Miller RG, Brooker S.

Chem Sci. 2016 Apr 21;7(4):2501-2505. doi: 10.1039/c5sc04583e. Epub 2016 Feb 9.

28.

Spin Crossover in Dinuclear N4S2 Iron(II) Thioether-Triazole Complexes: Access to [HS-HS], [HS-LS], and [LS-LS] States.

Hogue RW, Feltham HL, Miller RG, Brooker S.

Inorg Chem. 2016 May 2;55(9):4152-65. doi: 10.1021/acs.inorgchem.5b02851. Epub 2016 Apr 15.

PMID:
27082018
29.

The Creation of a Biocontainment Unit at a Tertiary Care Hospital. The Johns Hopkins Medicine Experience.

Garibaldi BT, Kelen GD, Brower RG, Bova G, Ernst N, Reimers M, Langlotz R, Gimburg A, Iati M, Smith C, MacConnell S, James H, Lewin JJ, Trexler P, Black MA, Lynch C, Clarke W, Marzinke MA, Sokoll LJ, Carroll KC, Parish NM, Dionne K, Biddison EL, Gwon HS, Sauer L, Hill P, Newton SM, Garrett MR, Miller RG, Perl TM, Maragakis LL.

Ann Am Thorac Soc. 2016 May;13(5):600-8. doi: 10.1513/AnnalsATS.201509-587PS.

PMID:
27057583
30.

Impact of a community-based lifestyle intervention program on health-related quality of life.

Eaglehouse YL, Schafer GL, Arena VC, Kramer MK, Miller RG, Kriska AM.

Qual Life Res. 2016 Aug;25(8):1903-12. doi: 10.1007/s11136-016-1240-7. Epub 2016 Feb 20.

31.

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM Jr, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM Jr, Hehir MK, Hobson-Webb LD, Howard JF Jr, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI.

Muscle Nerve. 2016 Feb;53(2):165-8. doi: 10.1002/mus.25009. Epub 2015 Dec 21. No abstract available.

PMID:
26662952
32.

Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis.

Jenkins JA, Sakamuri S, Katz JS, Forshew DA, Guion L, Moore D, Miller RG.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):213-20. doi: 10.3109/21678421.2015.1112406. Epub 2015 Nov 30.

PMID:
26618854
33.

Pressure induced separation of phase-transition-triggered-abrupt vs. gradual components of spin crossover.

Miller RG, Narayanaswamy S, Clark SM, Dera P, Jameson GB, Tallon JL, Brooker S.

Dalton Trans. 2015 Dec 28;44(48):20843-9. doi: 10.1039/c5dt03795f. Epub 2015 Oct 15.

PMID:
26468868
34.

Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes.

Eny KM, Orchard TJ, Miller RG, Maynard J, Grant DM, Costacou T, Cleary PA, Braffett BH, Paterson AD; DCCT/EDIC Research Group.

Diabetes Technol Ther. 2015 Oct;17(10):726-34. doi: 10.1089/dia.2015.0017. Epub 2015 Jul 20.

35.

Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, Orchard TJ.

Acta Diabetol. 2016 Apr;53(2):243-50. doi: 10.1007/s00592-015-0770-8. Epub 2015 May 24.

36.

Spin Crossover, Reversible Redox, and Supramolecular Interactions in 3d Complexes of 4-(4-Pyridyl)-2,5-dipyrazyl-pyridine.

Miller RG, Brooker S.

Inorg Chem. 2015 Jun 1;54(11):5398-409. doi: 10.1021/acs.inorgchem.5b00428. Epub 2015 May 13.

PMID:
25970648
37.

Antivibration gloves: effects on vascular and sensorineural function, an animal model.

Krajnak K, Waugh S, Johnson C, Miller RG, Welcome D, Xu X, Warren C, Sarkisian S, Andrew M, Dong RG.

J Toxicol Environ Health A. 2015;78(9):571-82. doi: 10.1080/15287394.2015.1014079.

38.

White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes.

Nunley KA, Ryan CM, Orchard TJ, Aizenstein HJ, Jennings JR, Ryan J, Zgibor JC, Boudreau RM, Costacou T, Maynard JD, Miller RG, Rosano C.

Neurology. 2015 May 19;84(20):2062-9. doi: 10.1212/WNL.0000000000001582. Epub 2015 Apr 22.

39.

Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.

Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A; Phase 2 Trial NP001 Investigators.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun.

40.

Improving employee health: evaluation of a worksite lifestyle change program to decrease risk factors for diabetes and cardiovascular disease.

Kramer MK, Molenaar DM, Arena VC, Venditti EM, Meehan RJ, Miller RG, Vanderwood KK, Eaglehouse Y, Kriska AM.

J Occup Environ Med. 2015 Mar;57(3):284-91. doi: 10.1097/JOM.0000000000000350.

41.

Pyrazine-imide complexes: reversible redox and MOF building blocks.

Cowan MG, Miller RG, Brooker S.

Dalton Trans. 2015 Feb 14;44(6):2880-92. doi: 10.1039/c4dt03407d.

PMID:
25563508
42.

Evaluation of a community Diabetes Prevention Program delivered by diabetes educators in the United States: one-year follow up.

Kramer MK, Miller RG, Siminerio LM.

Diabetes Res Clin Pract. 2014 Dec;106(3):e49-52. doi: 10.1016/j.diabres.2014.10.012. Epub 2014 Oct 23.

PMID:
25467620
43.

Evaluation of non-invasive screening measures to identify individuals with prediabetes.

Vanderwood KK, Kramer MK, Miller RG, Arena VC, Kriska AM.

Diabetes Res Clin Pract. 2015 Jan;107(1):194-201. doi: 10.1016/j.diabres.2014.06.003. Epub 2014 Jun 21.

44.

Selective gas adsorption in a pair of robust isostructural MOFs differing in framework charge and anion loading.

Cowan MG, Miller RG, Southon PD, Price JR, Yazaydin O, Lane JR, Kepert CJ, Brooker S.

Inorg Chem. 2014 Nov 17;53(22):12076-83. doi: 10.1021/ic501876m. Epub 2014 Oct 2.

PMID:
25274042
45.

NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.

Miller RG, Zhang R, Block G, Katz J, Barohn R, Kasarskis E, Forshew D, Gopalakrishnan V, McGrath MS.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):601-9. doi: 10.3109/21678421.2014.951940. Epub 2014 Sep 5.

46.

Predicting major outcomes in type 1 diabetes: a model development and validation study.

Soedamah-Muthu SS, Vergouwe Y, Costacou T, Miller RG, Zgibor J, Chaturvedi N, Snell-Bergeon JK, Maahs DM, Rewers M, Forsblom C, Harjutsalo V, Groop PH, Fuller JH, Moons KG, Orchard TJ.

Diabetologia. 2014 Nov;57(11):2304-14. doi: 10.1007/s00125-014-3358-x. Epub 2014 Sep 4.

47.

Seeking a measure of clinically meaningful change in ALS.

McElhiney M, Rabkin JG, Goetz R, Katz J, Miller RG, Forshew DA, David W, Cudkowicz M, Glass JD, Appel S, Simpson E, Mitsumoto H.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):398-405. doi: 10.3109/21678421.2014.942668. Epub 2014 Aug 15. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):627.

PMID:
25124889
48.

Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Miller RG, Brooks BR, Swain-Eng RJ, Basner RC, Carter GT, Casey P, Cohen AB, Dubinsky R, Forshew D, Jackson CE, Kasarskis E, Procaccini NJ, Sanjak M, Tolin FP.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):165-8. doi: 10.3109/21678421.2013.875706. Epub 2014 Apr 7. No abstract available.

PMID:
24707820
49.

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24.

50.

Hysteretic spin crossover in iron(II) complexes of a new pyridine-triazole-pyrazine ligand is tuned by choice of NCE co-ligand.

Hogue RW, Miller RG, White NG, Feltham HL, Jameson GN, Brooker S.

Chem Commun (Camb). 2014 Feb 11;50(12):1435-7. doi: 10.1039/c3cc43922d.

PMID:
24352584

Supplemental Content

Loading ...
Support Center